Skip to content

Information Technology Methodology for Patient Motivation in Diabetes Management.

Reinforcement of Adherence to Prescription Recommendations in Diabetic Patients Using Short Message Service (SMS)- A Pilot Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00727896
Enrollment
200
Registered
2008-08-04
Start date
2008-08-31
Completion date
2010-04-30
Last updated
2011-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Life style modification,, Type 2 diabetes,, SMS,, Patient adherence

Brief summary

Type 2 diabetes is a chronic metabolic disorder requiring lifestyle modification and medicines, adherence to which has to be practised on a daily basis. Motivation of patients to adhere to treatment is difficult in clinical practice. It is well documented that majority of patients do not reach the glycaemic targets even in the centres of excellence. Regular short service messages (SMS) through cell phones could have a positive effect on behaviour and adherence to life style changes and compliance to drugs. It may be practical and feasible to use information technology as an effective and simple tool for motivating patients to adhere to the prescribed treatment regimen. In diabetic patients, frequent reminders regarding the need for adherence to LSM and drugs by the medical professionals will improve the compliance.

Detailed description

In diabetic patients, frequent reminders by the medical professionals on the need for adherence to Life Style Modification (LSM) and drugs will improve the compliance. SMS may be an effective and cheap tool of communication. Improved compliance is likely to result in better glycaemic control. Out of total number of 200, consecutive randomization of 100 patients each to SMS or usual care arms will be done. Patients in the SMS group will get SMS once in 3 days as a reminder. Patients will be reviewed at 3, 6, 9 and 12 months from the date of randomization Fasting and 2hr postprandial glucose and HbA1c will be tested during each visit. At baseline and at the end of the study, lipids, and renal function test will also be done. A validated questionnaire will be used to assess physical activity, diet habits, adherence to drug prescriptions and frequency of monitoring of blood glucose. . Body weight, blood pressure, biochemical variables, scores for diet and physical activity and compliance to drugs, will be compared using students 't' test or chi-square test as relevant.

Interventions

BEHAVIORALPre-coded messages

Earlier life style modification and existing drug therapy was used and now SMS is added as a tool for reminder

Life style modification and drug therapy

Sponsors

India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male or female, 30-65 yrs of age at the time of entry and have type 2 diabetes for a minimum period of 5 years. * HbA1C ranging 8.0-10.0% * Patients either receiving OHA and / or insulin

Exclusion criteria

* Type 1 diabetes * Patients with history of blindness, decreased vision * Serious vascular complications : * Cancer

Design outcomes

Primary

MeasureTime frame
Behavioural changes resulting in diet, better adherence to treatment.At intervals of three months for one year

Secondary

MeasureTime frame
Reduction in HbA1c, other glycemic measures and improvement in blood lipid parametersAnnual

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026